Inhibrx Biosciences, Inc.
Ticker: 2007919
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY25 | Q2 FY24 | Q3 FY23 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 2.00+53.8% | 1.30+1200.0% | 0.10-16.7% | 0.12 |
| Total Income | 2.00+53.8% | 1.30+1200.0% | 0.10-16.7% | 0.12 |
| EXPENSES | ||||
| Expenditure | 33.74+17.6% | 28.69-82.2% | 161.00+250.4% | 45.95 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||
| PBT | -38.73-35.2% | -28.65-101.5% | 1.9K+3687.6% | -51.79 |
| Net Profit | -38.73-35.2% | -28.65-101.5% | 1.9K+3687.6% | -51.79 |
| KEY METRICS | ||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00%-200.00pp | 100.00%+200.00pp | -100.00% |
| EPS | -2.46-33.0% | -1.85-101.5% | 127.10+2995.2% | -4.39 |
Corporate Events
Board MeetingINBX
20263Jun
Board Meeting
Election of Class II directors and ratification of the indep…
SEC Filing ↗